Clinical masks of primary cardiac tumors: a clinical case report
- Authors: Uryas’yev O.M.1, Solov’yeva A.V.1, Berstneva S.V.1, Kostyuk A.V.1, Samokhina Y.A.1
-
Affiliations:
- Ryazan State Medical University
- Issue: Vol 32, No 4 (2024)
- Pages: 627-636
- Section: Clinical reports
- URL: https://bakhtiniada.ru/pavlovj/article/view/279493
- DOI: https://doi.org/10.17816/PAVLOVJ340864
- ID: 279493
Cite item
Abstract
INTRODUCTION: Primary cardiac tumors are rare, 75% of them are benign, half of which are myxomas. Despite histological benignity, untimely diagnosed myxoma can have serious complications. Myxoma is characterized by non-specific symptoms, however, a typical triad of atrial myxoma symptoms is distinguished: (1) symptoms of mitral valve obstruction manifested by heart failure and weakness, (2) symptoms of embolism and (3) systemic manifestations.
AIM: Illustration of the variety of clinical manifestations, discussion of diagnostic difficulties, formation of clinical alertness in the observation of left atrial myxoma.
MATERIALS AND METHODS: Left atrial myxoma in a 49-year-old male patient debuted at the age of 44 with the development of a transient cerebrovascular disorder in the right carotid system manifested by dysarthria and paresis of the facial muscles; at that time, no echocardiographic (EchoCG) examination was conducted. Several years later, the clinical presentation of heart failure manifested: shortness of breath when walking, edema of lower limbs. EchoCG revealed a sizable mass in the left atrium 33 mm × 55 mm fixed to the interatrial septum, prolapsing into the left ventricle and partially stenosing the left atrioventricular opening. Dilation of both atria, of the right ventricle, pronounced pulmonary hypertension, 2-degree regurgitation on the tricuspid valve, 2-degree regurgitation on the pulmonic valve, hydropericardium and hydrothorax on the right were found. The clinical case was also characterized by the developed bilateral thrombosis of the superficial femoral vein with signs of flotation. The development of venous thrombosis in a patient with cardiac myxoma can probably be considered as a systemic manifestation of the tumor disease. After compensation for the heart failure and implantation of a cava filter, the tumor was surgically removed, the morphological picture corresponded to cardiac myxoma with hemorrhages of various ages.
CONCLUSION: The case demonstrates the need for performing EchoCG in a transient ischemic attack, in ischemic stroke, to screen for intracardiac masses capable of frustrating cerebral circulation by cardioembolic mechanism, especially at a young age in the absence of other cardiovascular risk factors. The clinical picture consistently showed all the symptoms of the classic triad of cardiac myxoma: embolic syndrome, symptoms of mitral valve obstruction and systemic manifestations. The prognosis for patients with cardiac myxoma depends on the severity of thromboembolic syndrome and severity of heart failure. Timely diagnosis and surgical removal of cardiac myxoma provide a favorable prognosis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Oleg M. Uryas’yev
Ryazan State Medical University
Email: Uryasev08@yandex.ru
ORCID iD: 0000-0001-8693-4696
SPIN-code: 7903-4609
Scopus Author ID: 57195313767
ResearcherId: S-6270-2016
MD, Dr. Sci. (Med.), Professor
Russian Federation, RyazanAleksandra V. Solov’yeva
Ryazan State Medical University
Author for correspondence.
Email: savva2005@bk.ru
ORCID iD: 0000-0001-7896-6356
SPIN-code: 1943-7765
MD, Dr. Sci. (Med.), Associate Professor
Russian Federation, RyazanSvetlana V. Berstneva
Ryazan State Medical University
Email: berst.ru@mail.ru
ORCID iD: 0000-0002-3141-4199
SPIN-code: 6722-3203
MD, Dr. Sci. (Med), Associate Professor
Russian Federation, RyazanAnastasiya V. Kostyuk
Ryazan State Medical University
Email: anastasia1999kostuk@mail.ru
ORCID iD: 0000-0001-8032-8011
SPIN-code: 4466-2722
Russian Federation, Ryazan
Yuliya A. Samokhina
Ryazan State Medical University
Email: yulia-samoxa@mail.ru
ORCID iD: 0000-0001-7024-4295
Russian Federation, Ryazan
References
- Zakharyan EA. Сardiac myxomas: the history of study, modern methods of diagnostics and treatment. Krymskiy Terapevticheskiy Zhurnal. 2012;(2):27–33. (In Russ).
- MacGowan SW, Sidhu P, Aherne T, et al. Atrial myxoma: national incidence, diagnosis and surgical management. Ir J Med Sci. 1993; 162(6):223–6. doi: 10.1007/bf02945200
- Ekinci EI, Donnan GA. Neurological manifestations of cardiac myxoma: a review of the literature and report of cases. Intern Med J. 2004;34(5):243–9. doi: 10.1111/j.1444-0903.2004.00563.x
- Kohno N, Kawakami Y, Hamada C, et al. Cerebral embolism associated with left atrial myxoma that was treated with thrombolytic therapy. Case Rep Neurol. 2012;4(1):38–42. doi: 10.1159/000336179
- Al-Musawi M, Rubay D, Ohanisian L, et al. Acute Myocardial Ischemia Secondary to Embolization of Left Atrial Myxoma to Coronary Artery. Cureus. 2020;12(7):e9260. doi: 10.7759/cureus.9260
- Bernatchez J, Gaudreault V, Vincent G, et al. Left Atrial Myxoma Presenting as an Embolic Shower: A Case Report and Review of Literature. Ann Vasc Surg. 2018;53:266.e13–e20. doi: 10.1016/j.avsg.2018.04.024
- Knepper LE, Biller J, Adams HP, et al. Neurologic manifestations of atrial myxoma: a 12-year experience and review. Stroke. 1998; 19(11):1435–40. doi: 10.1161/01.str.19.11.1435
- Medrano–Plana Y, Hernández–Borroto CE, González–Chinea R, et al. Infarto cerebral embólico como complicación perioperatoria de un mixoma auricular. Cir Cir. 2022;90(2):248–50. doi: 10.24875/ciru.20001006
- Le BD, De Lemos JA, Wait MA, et al. Left hemiparesis from atrial myxoma emboli. Cardiol Rev. 2003;11(1):41–4. doi: 10.1097/00045415-200301000-00008
- Chong JY, Vraniak P, Etienne M, et al. Intravenous thrombolytic treatment of acute ischmemic stroke associated with left atrial myxoma: a case report. J Stroke Cerebrovasc Dis. 2005;14(1):39–41. doi: 10.1016/j.jstrokecerebrovasdis.2004.09.002
- Vico Besó L, Zúñiga Cedó E. Tromboembolismo pulmonar secundario a mixoma de aurícula derecha [Secondary pulmonary embolism to right atrial myxoma]. Semergen. 2013;39(7):e54–6. (In Spanish). doi: 10.1016/j.semerg.2012.05.016
- Merello L, Elton V, González D, et al. Mixoma cardíaco: experiencia de 28 años en resección quirúrgica [Cardiac myxomas. Analysis of 78 cases]. Rev Med Chil. 2020;148(1):78–82. (In Spanish). doi: 10.4067/s0034-98872020000100078
- Petrov VS. Pulmonary hypertension in patients with rheumatic heart disease. Nauka Molodykh (Eruditio Juvenium). 2019;7(3):400–7. (In Russ). doi: 10.23888/HMJ201973400-407
- Yuan S–M, Humuruola G. Stroke of a cardiac myxoma origin. Rev Bras Cir Cardiovasc. 2015;30(2):225–34. doi: 10.5935/1678-9741.20150022
- Klinicheskiye rekomendatsii “Ishemicheskiy insul’t i tranzitornaya ishemicheskaya ataka u vzroslykh”. 2021. Available at: https://cr.minzdrav.gov.ru/schema/171_2?ysclid=lyms7140pt62940214. Accessed: 2023 April 20. (In Russ).
- Kalçık M, Bayam E, Güner A, et al. Evaluation of the potential predictors of embolism in patients with left atrial myxoma. Echocardiography. 2019;36(5):837–43. doi: 10.1111/echo.14331
- Cao GF, Bi Q, Cao L, et al. The clinical characteristics of stroke in young patients with cardiac myxoma. Zhonghua Nei Ke Za Zhi. 2017;56(4):263–7. (In Chinese). doi: 10.3760/cma.j.issn.0578-1426. 2017.04.005
- Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine (Baltimore). 2001;80(3):159–72. doi: 10.1097/00005792-200105000-00002
- Karlof E, Salzberg SP, Anyanwu AC, et al. How fast does an atrial myxoma grow? Ann Thorac Surg. 2006;82(4):1510–2. doi: 10.1016/j.athoracsur.2005.11.014
- Zhang R–D, Zeng Z–H, Zheng J–Y, et al. Left atrial myxoma complicated with multi-system embolization. J Cardiothorac Surg. 2017;12(1):76. doi: 10.1186/s13019-017-0640-2
- Petrikov AS, Prostov II. Extended therapy and secondary prevention of venous thromboembolic complications. I. P. Pavlov Russian Medical Biological Herald. 2020;28(4):548–66. (In Russ). doi: 10.23888/PAVLOVJ 2020284548-566
- Osipova OA, Suyazova SB, Vlasenko MA, et al. Role of proinflammatory cytokines in chronic heart failure. I. P. Pavlov Russian Medical Biological Herald. 2013;(2):130–5. (In Russ).
Supplementary files
